Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tirtha K Das

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Drug Discovery Today. Technologies|September 21, 2013
A Drosophila approach to thyroid cancer therapeuticsTirtha K Das, Ross L Cagan
Endocrine-Related Cancer|January 20, 2018
Non-mammalian models of multiple endocrine neoplasia type 2Tirtha K Das, Ross L Cagan
Cancer Research|May 31, 2018
Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular ResistanceTirtha K Das, Jessica Esernio, Ross L Cagan
Developmental Dynamics : an Official Publication of the American Association of Anatomists|November 1, 2011
Drosophila cancer modelsVivek A Rudrapatna, Ross L Cagan, Tirtha K Das
Nature|June 9, 2012
Chemical genetic discovery of targets and anti-targets for cancer polypharmacologyArvin C Dar, Tirtha K Das, Kevan M Shokat, et al.
Iscience|April 15, 2021
Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacyTirtha K Das, Jared Gatto, Rupa Mirmira, et al.
Disease Models & Mechanisms|May 9, 2024
Functional exploration of copy number alterations in a Drosophila model of triple-negative breast cancerJennifer E L Diaz, Vanessa Barcessat, Christian Bahamon, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor DevelopmentDibyendu Dana, Tuhin Das, Athena Choi, et al.
Chemical Biology & Drug Design|June 26, 2012
Design, synthesis, and evaluation of 2-(arylsulfonyl)oxiranes as cell-permeable covalent inhibitors of protein tyrosine phosphatasesDibyendu Dana, Tirtha K Das, Ish Kumar, et al.
Plos One|July 7, 2012
γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizersShibo Fu, Ying Yang, Tirtha K Das, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Drug Discovery Today. Technologies|September 21, 2013
A Drosophila approach to thyroid cancer therapeuticsTirtha K Das, Ross L Cagan
Endocrine-Related Cancer|January 20, 2018
Non-mammalian models of multiple endocrine neoplasia type 2Tirtha K Das, Ross L Cagan
Cancer Research|May 31, 2018
Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular ResistanceTirtha K Das, Jessica Esernio, Ross L Cagan
Developmental Dynamics : an Official Publication of the American Association of Anatomists|November 1, 2011
Drosophila cancer modelsVivek A Rudrapatna, Ross L Cagan, Tirtha K Das
Nature|June 9, 2012
Chemical genetic discovery of targets and anti-targets for cancer polypharmacologyArvin C Dar, Tirtha K Das, Kevan M Shokat, et al.
Iscience|April 15, 2021
Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacyTirtha K Das, Jared Gatto, Rupa Mirmira, et al.
Disease Models & Mechanisms|May 9, 2024
Functional exploration of copy number alterations in a Drosophila model of triple-negative breast cancerJennifer E L Diaz, Vanessa Barcessat, Christian Bahamon, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor DevelopmentDibyendu Dana, Tuhin Das, Athena Choi, et al.
Chemical Biology & Drug Design|June 26, 2012
Design, synthesis, and evaluation of 2-(arylsulfonyl)oxiranes as cell-permeable covalent inhibitors of protein tyrosine phosphatasesDibyendu Dana, Tirtha K Das, Ish Kumar, et al.
Plos One|July 7, 2012
γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizersShibo Fu, Ying Yang, Tirtha K Das, et al.
Pageof 2